| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |